Novavax and Serum Institutes COVID-19 vaccine receives EUA in Indonesia 

Novavax Inc, a Biotechnology firm and Serum Institute of India announced that they have received the first emergency use authorization for the COVID-19 vaccine in Indonesia.

 Highlights

•        Novavax’s Covi...

SII CEO POONAWALLA THANKS US PRESIDENT BIDEN, INDIAN EAM JAISHANKAR FOR POLICY CHANGE ON VACCINE

Highlights

• In a response to Poonawalla’s tweet, the India’s EAM said that the “Indian diplomacy is focussed on securing the vaccine supply chain.”

Responding to the decision made by the United States to remove Defense Production Act priority rati...

SERUM IN TALKS WITH US GOVERNMENT REGARDING RAW MATERIAL REQUIRED FOR COVOVAX

Highlights

• Last month the SII CEO Adar Poonawalla had urged the President of the US, Joe Biden to lift the embargo

According to the sources, the Serum Institute of India (SII) has approached the United States government in order to clarify that it needs the supply of ra...

US SAYS IT REMEMBERS INDIA’S GENEROSITY IN EARLY DAYS OF COVID-19 PANDEMIC

Highlights

• The United States on Tuesday said it will be delivering raw materials to the Serum Institute of India (SII) for the manufacturing of the Oxford-AstraZeneca Covishield vaccine

• After denying initially, the US has agreed to help India in every way possibl...

SII CEO ADAR POONAWALLA URGES U.S. PRESIDENT BIDEN TO LIFT EMBARGO ON COVID-19 VACCINE RAW MATERIALS

Highlights

• The Serum Institute of India CEO Adar Poonawalla on Friday urged the President of the US, Joe Biden to lift the embargo on COVID-19 vaccine raw materials

• The Serum Institute CEO had recently said that he understands the increasing demand for retaining ...

US, EUROPE BAN EXPORT OF CRITICAL RAW MATERIALS REQUIRED TO MAKE COVID VACCINES: SII CEO POONAWALLA

Highlights

• The United States along with the European nations have imposed a ban on export of critical raw materials needed to manufacture the vaccine for dreadful coronavirus

• The Serum Institute CEO said that he understands the increasing demand for retaining all...

COVISHIELD VACCINE MAYBE RECOMMENDED FOR INTERNATIONAL USE

HIGHLIGHTS

• AstraZeneca is in talks with governments of many countries.
• AstraZeneca is also engaging with multilateral organizations and many other partners around the world.
• AstraZeneca wants broad and equitable access to the vaccine for ev...

SII RELEASES FAQ FACTSHEET FOR COVISHIELD VACCINE

HIGHLIGHTS

• SII has released FAQ Factsheet for Covishield Vaccine.
• The new factsheet details information for vaccine recipients regarding the benefits and common side-effects of the Covishield vaccine.
• The Covishield has been approved for re...

COVID-19 VACCINE: NOVAVAX TO DELIVER 100 MILLION DOSES TO THE U.S. BY JANUARY 2021

Highlights

• Novavax in the month of August had inked a deal with Serum Institute of India, the largest producer of vaccines in the world in order to produce a minimum of its COVID-19 vaccine candidate

• The U.S. drug developer had previously said that it will supply...

SERUM INSTITUTE CEO WARNS OF COVID-19 VACCINE SHORTAGE TILL 2024

HIGHLIGHTS

• Serum Institute CEO says that till 2024, coronavirus vaccine availability will not be enough.
• Two doses of vaccine are required to create immunity against coronavirus.

On Monday, 14 SEP 2020, Adar Poonawalla, the CEO of Se...

COVID-19 VACCINE: SERUM INSTITUTE OF INDIA TO COMMENCE PHASE II TRIAL OF OXFORD VACCINE TODAY

According to the sources, the phase II human clinical trial of the Oxford COVID-19 vaccine candidate by the Serum Institute of India (SII), Pune will start from today. Bharati Vidyapeeth Medical College and Hospital in Pune is the site where this observer-blind, randomised controlled study to det...

COVID-19 VACCINE: SERUM INSTITUTE OF INDIA TO BEGIN PHASE 2 TRIALS OF OXFORD VACCINE THIS WEEK

Highlights

• The Serum Institute of India has stated that it has shortlisted 10 centres across the nation to conduct Phase II and Phase III human clinical trials of COVID-19 vaccine developed by the University of Oxford

• On Monday, the national expert group on vacci...

INDIA’S COVID-19 TALLY AT 27,02,742, DEATH TOLL GOES UP TO 51,797

• Current Total Cases: 2,702,742

• Total Deaths : 51,797

• Cumulative recoveries : 1,977,779

• Active cases: 673,166

• Top five states that has the maximum number of cases : 

Maharashtra: Cases 604,358, number of deat...

COVID-19 VACCINE: SERUM INSTITUTE OF INDIA CAPS PROPOSED VACCINE AT $3/DOSE

Highlights

• The Serum Institute of India, Pune has signed an agreement with Gavi and Bill & Melinda Gates Foundation to accelerate the development and distribution of up to 100 million doses

• As per the agreement signed by the Serum Institute with AstraZeneca a...

NOVAVAX, SERUM INSTITUTE OF INDIA JOIN HANDS TO SUPPLY COVID-19 VACCINE

Highlights

• The Serum Institute of India will have exclusive rights for the COVID-19 vaccine in India and non-exclusive rights during the pandemic period in all countries except those designated as upper-middle or high-income nations

• The COVID-19 vaccine developed...

COVID-19 VACCINE: DCGI APPROVES PHASE 2 AND 3 CLINICAL TRIALS OF OXFORD VACCINE BY SERUM INSTITUTE

Highlights

• DCGI Dr V G Somani granted approval for conducting phase 2 and 3 human clinical trials by the SII

• ‘Covishield’ a potential vaccine for COVID-19 has been developed by the University of Oxford

• Before starting the phase 3 tria...

DR FAUCI: INDIA CRUCIAL FOR VACCINE PRODUCTION ONCE A COVID VACCINE IS FOUND

Highlights:

•     Director NIAID, Dr. Fauci, US emphasizes on India’s role in vaccine production

•     America is monitoring Indian covid vaccine progress

Dr. Fauci, America's leading infectious disease expe...

PUNE-BASED MYLAB GETS COMMERCIAL APPROVAL FROM ICMR FOR ANTIGEN KITS

Highlights

• The antigen kit developed by Mylab Discovery Solutions will cost Rs 450 per unit

• Serum Institute of India, CEO Adar Poonawalla has invested over Rs 100 crore and owns less than 50 percent stake in Mylab

• This antigen kit was co-develope...

INDIA REPORTS ITS BIGGEST SINGLE-DAY SPIKE OF 45,720 COVID-19 CASES IN LAST 24 HRS

• Current Total Cases: 1,238,635

• Total Deaths : 29,861

• Cumulative recoveries : 782,607

• Active cases: 426,167

• Top five states that has the maximum number of cases : 

Maharashtra: Cases 337,607, number of deaths...

INDIA’S COVID-19 TALLY NEARS 12 LAKH, DEATH TOLL AT 28,732

• Current Total Cases: 1,192,915

• Total Deaths : 28,732

• Cumulative recoveries : 753,050

• Active cases: 411,133

• Top five states that has the maximum number of cases : 

Maharashtra: Cases 327,031, number of deaths...